publication date: Mar. 29, 2019


Antoni Ribas named AACR president-elect for 2019-2020 term

The members of the American Association for Cancer Research have elected Antoni Ribas as president-elect for 2019–2020. He will officially become president-elect at the AACR Annual Meeting 2019, to be held in Atlanta, March 29–April 3, and he will assume the presidency in April 2020 at the AACR Annual Meeting in San Diego.

The voting members of the AACR have also elected five members to serve on the AACR board of directors for the 2019–2022 term. These new directors will begin their terms at the AACR Annual Meeting 2019.

Ribas is professor of Medicine at the David Geffen School of Medicine at the University of California Los Angeles; director of the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program; and director of the Parker Institute for Cancer Immunotherapy Center at UCLA. He is an internationally recognized physician-scientist whose translational and clinical research focuses on developing therapeutic options for patients with malignant melanoma.

Ribas, an AACR member since 1999, is currently serving as a member of the AACR board of directors, as vice chair for the AACR Annual Meeting 2019 Program Committee, as chair of the AACR Annual Meeting 2020 Program Committee, as co-chair of the 2019 Combination Therapies Future of Cancer Research Innovation Summit, and as a scientific editor of the AACR journal Cancer Discovery.

Among his other contributions to the AACR, he served as co-chair of the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in 2017 and 2018, and as co-chair of the AACR Tumor Immunology and Immunotherapy Conference in 2016. He has also been a member of several important committees for the AACR.

The following five … Continue reading Antoni Ribas named AACR president-elect for 2019-2020 term

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.